Corpus ID: 6079824

Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. Which one has better affect on acne, hirsutism, and weight change.

@article{Sanam2011DesogestrelethinylestradiolVL,
  title={Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. Which one has better affect on acne, hirsutism, and weight change.},
  author={M. Sanam and Omidvar Ziba},
  journal={Saudi medical journal},
  year={2011},
  volume={32 1},
  pages={
          23-6
        }
}
  • M. Sanam, Omidvar Ziba
  • Published 2011
  • Medicine
  • Saudi medical journal
    • OBJECTIVE To compare complications of third and second generation oral contraceptive pills (OCPs). METHODS In a randomized clinical trial from October 2007 to October 2008, 100 healthy women of reproductive age referred to Amir Hospital Family Planning Clinic and some heath centers in Semnan, Iran were randomized in 2 equal groups. They received either a third generation OCP (150 microgram desogestrel [DSG] + 30 microgram ethinylestradiol [EE]) or a second generation type (150 microgram… CONTINUE READING
    View on PubMed
    smj.org.sa
    18 Citations
    Background Citations
    5
    18 Citations
    Citation Type

    Citation Type

    Levonorgestrel vs combined oral contraceptive pills in treatment of female acne and hirsutism
    Effects of ethinyl estradiol plus desogestrel on premenstrual symptoms in Iranian women.
    • 4
    Comparative Study of Desogestrel- Containing Oral Contraceptive and Levonorgestrel- Containing Oral Contraceptive in Dysfunctional Uterine Bleeding
    • PDF
    Comparing the Administration of Letrozole and Megestrol Acetate in the Treatment of Women with Simple Endometrial Hyperplasia without Atypia: A Randomized Clinical Trial
    • 3
    A Review of hormone-based therapies to treat adult acne vulgaris in women
    • 14
    Synchronizing Pharmacotherapy in Acne with Review of Clinical Care
    • 3
    Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    • 32
    • PDF
    Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments
    • 22
    The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis
    • 132
    • PDF
    Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.
    • 277
    • PDF

    References

    SHOWING 1-10 OF 24 REFERENCES
    Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism.
    • 51
    A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
    • 67
    Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    • 64
    Latin american experience with two low-dose oral contraceptives containing 30 microg ethinylestradiol/75 microg gestodene and 20 microg ethinylestradiol/150 microg desogestrel.
    • 5
    A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris.
    • 53
    Latin American experience with two low–dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel
    • 18
    Effect of low-dose oral contraceptives on androgenic markers and acne.
    • 100
    Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial.
    • 24
    A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment.
    • 32
    Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara®) and EE/LNG (Microgynon®)
    • 84
    • PDF